Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery. (se deschide o fereastră nouă)

Elbohoty AE, Mohammed WE, Sweed M, Bahaa Eldin AM, Nabhan A, Abd-El-Maeboud KH.

Sursă‎: Int J Gynaecol Obstet 2016;134(3):324-8.

Index‎: PubMed 27350226

https://www.ncbi.nlm.nih.gov/pubmed/27350226 (se deschide o fereastră nouă)

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. (se deschide o fereastră nouă)

Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gulmezoglu AM, Hofmeyr GJ, Coomarasamy A

Sursă‎: Cochrane Database Syst Rev 2018;4:CD011689.

Index‎: PubMed 29693726

DOI‎: 10.1002/14651858.CD011689.pub2

https://www.ncbi.nlm.nih.gov/pubmed/29693726 (se deschide o fereastră nouă)

Preventing postpartum hemorrhage after cesarean delivery: A network meta-analysis of available pharmacologic agents. (se deschide o fereastră nouă)

Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT

Sursă‎: Am J Obstet Gynecol.

Index‎: PubMed 34534498

DOI‎: 10.1016/j.ajog.2021.08.060

https://pubmed.ncbi.nlm.nih.gov/34534498/ (se deschide o fereastră nouă)

A randomised controlled trial comparing oxytocin and oxytocin + ergometrine for prevention of postpartum haemorrhage at caesarean section. (se deschide o fereastră nouă)

Koen S, Snyman LC, Pattinson RC, Makin JA.

Sursă‎: S Afr Med J 2016;106(4):399-402.

Index‎: PubMed 27032858

https://www.ncbi.nlm.nih.gov/pubmed/27032858 (se deschide o fereastră nouă)

Prophylactic use of ergot alkaloids in the third stage of labour. (se deschide o fereastră nouă)

Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM.

Sursă‎: Cochrane Database Syst Rev 2007;(2):CD005456.

Index‎: PubMed 17443592

https://www.ncbi.nlm.nih.gov/pubmed/17443592 (se deschide o fereastră nouă)

Treatment for primary postpartum haemorrhage. (se deschide o fereastră nouă)

Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z.

Sursă‎: Cochrane Database Syst Rev 2014;(2):CD003249.

Index‎: PubMed 24523225

https://www.ncbi.nlm.nih.gov/pubmed/24523225 (se deschide o fereastră nouă)

Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. (se deschide o fereastră nouă)

Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC.

Sursă‎: Obstet Gynecol 2001;98(3):386-90.

Index‎: PubMed 11530117

https://www.ncbi.nlm.nih.gov/pubmed/11530117 (se deschide o fereastră nouă)

Prospective randomized trial of oxytocin administration for active management of the third stage of labor. (se deschide o fereastră nouă)

Oguz Orhan E, Dilbaz B, Aksakal SE, Altınbas S, Erkaya S.

Sursă‎: Int J Gynaecol Obstet 2014;127(2):175-9.

Index‎: PubMed 25108586

https://www.ncbi.nlm.nih.gov/pubmed/25108586 (se deschide o fereastră nouă)

A randomized clinical trial of preoperative versus postoperative misoprostol in elective cesarean delivery. (se deschide o fereastră nouă)

Ragab A, Barakat R, Alsammani MA.

Sursă‎: Int J Gynaecol Obstet 2016;132(1):82-4.

Index‎: PubMed 26522140

DOI‎: 10.1016/j.ijgo.2015.06.057

https://www.ncbi.nlm.nih.gov/pubmed/26522140 (se deschide o fereastră nouă)

Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. (se deschide o fereastră nouă)

Roach MK, Abramovici A, Tita AT.

Sursă‎: Am J Perinatol 2013;30(7):523-8.

Index‎: PubMed 23208766

https://www.ncbi.nlm.nih.gov/pubmed/23208766 (se deschide o fereastră nouă)

Prostaglandin E2 analogue sulprostone for treatment of atonic postpartum hemorrhage. (se deschide o fereastră nouă)

Schmitz T, Tararbit K, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C; Pithagore6 Group.

Sursă‎: Obstet Gynecol 2011;118(2 Pt 1):257-65.

Index‎: PubMed 21775840

DOI‎: 10.1097/AOG.0b013e3182255335

https://www.ncbi.nlm.nih.gov/pubmed/21775840 (se deschide o fereastră nouă)

The effects of a peripartum strategy to prevent and treat primary postpartum haemorrhage at health facilities in Niger: a longitudinal, 72-month study. (se deschide o fereastră nouă)

Seim AR, Alassoum Z, Souley I, Bronzan R, Mounkaila A, Ahmed LA

Sursă‎: Lancet Glob Health. 2023 11(2):e287-e295.

Index‎: PubMed 36669809

DOI‎: 10.1016/S2214-109X(22)00518-6.

https://pubmed.ncbi.nlm.nih.gov/36669809/ (se deschide o fereastră nouă)

Intravenous sulprostone infusion in the treatment of retained placenta. (se deschide o fereastră nouă)

Stefanovic V, Paavonen J, Loukovaara M, Halmesmäki E, Ahonen J, Tikkanen M.

Sursă‎: Acta Obstet Gynecol Scand 2013;92(4):426-32.

Index‎: PubMed 22862433

DOI‎: 10.1111/j.1600-0412.2012.01506.x

https://www.ncbi.nlm.nih.gov/pubmed/22862433 (se deschide o fereastră nouă)

Carbetocin for preventing postpartum haemorrhage. (se deschide o fereastră nouă)

Su LL, Chong YS, Samuel M.

Sursă‎: Cochrane Database Syst Rev 2012;(4):CD005457.

Index‎: PubMed 22513931

https://www.ncbi.nlm.nih.gov/pubmed/22513931 (se deschide o fereastră nouă)

Prostaglandins for preventing postpartum haemorrhage. (se deschide o fereastră nouă)

Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM.

Sursă‎: Cochrane Database Syst Rev 2012;(8):CD000494.

Index‎: PubMed 22895917

DOI‎: 10.1002/14651858.CD000494.pub4

https://www.ncbi.nlm.nih.gov/pubmed/22895917 (se deschide o fereastră nouă)

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. (se deschide o fereastră nouă)

Westhoff G, Cotter AM, Tolosa JE.

Sursă‎: Cochrane Database Syst Rev 2013;(10):CD001808.

Index‎: PubMed 24173606

DOI‎: 10.1002/14651858.CD001808.pub2

https://www.ncbi.nlm.nih.gov/pubmed/24173606 (se deschide o fereastră nouă)